AI Can Help Us Know What Viruses Are Up To In The Oceans And In Our Guts

Discover Magazine - May 25, 2024

Libusha Kelly, Ph.D., describes a novel approach she and colleagues developed that annotates viral sequences using artificial intelligence, which may help researchers gain a greater understanding of viral activity in various environments. Dr. Kelly is an associate professor of systems & computational biology and of microbiology & immunology at Einstein, and a member of the Montefiore Einstein Comprehensive Cancer Center.

Additional coverage includes The Conversation, Salon, and Yahoo!News

Hunting a Changing Virus

The Scientist - July 01, 2021

Libusha Kelly, Ph.D., describes SARS-CoV-2 sequencing efforts at Einstein and Montefiore and calls for a robust national genomic sequencing program to help scientists detect, understand, and stay ahead of new and developing viral variants. Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.

Gut Bacteria Feast on the Pills We Pop

Chemical & Engineering News - September 10, 2019

Libusha Kelly, Ph.D., whose lab investigates how the gut microbiome interacts with different drugs, explains how microbes act “like tiny chemists.” Dr. Kelly is associate professor of systems & computational biology and of microbiology & immunology.

How Bacteria Could Protect Tumors From Anticancer Drugs

The Atlantic - September 20, 2017

Libusha Kelly, Ph.D., comments on a study showing some bacteria can protect tumors from anticancer drugs. Dr. Kelly is assistant professor of systems & computational biology and of microbiology & immunology.

Gut bacteria can stop cancer drugs from working

Nature - June 15, 2017

Libusha Kelly, Ph.D., and computational biology student Leah Guthrie discuss their study on individuals’ microbiomes and their effect on the body’s metabolism of the chemotherapy drug irinotecan. Dr. Kelly is assistant professor in the departments of systems & computational biology and microbiology & immunology.